Calcitonin-gene-related peptide (CGRP) is a 37-amino-acid vasodilatory peptide, of which two isoforms, αCGRP and βCGRP, have been described. The use of C-terminal fragments of CGRP peptide, such as human αCGRP-(8–37), has led to the pharmacological subdivision of CGRP receptors into CGRP-1 [high potency for binding of human αCGRP-(8–37)] and CGRP-2 (lower potency) receptors. We have recently developed BIBN4096BS, the first non-peptide CGRP antagonist, which has sub-nanomolar affinity for primate CGRP receptors. The use of BIBN4096BS has led to the discovery of further functional CGRP receptor heterogeneity in rat tissues. To further exploit BIBN4096BS as a pharmacological tool, we used BIBN4096BS in pig left anterior descending coronary vessels and cerebral basilar arteries, and compared functional with molecular data, characterizing CGRP receptor components. Our data show that, apart from a subdivision into CGRP-1 and -2 receptors, BIBN4096BS reveals additional functional differences between the actions of αCGRP and βCGRP. However, evidence for CGRP receptor heterogeneity on a molecular level is scarce.
Skip Nav Destination
Article navigation
August 2002
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Conference Article|
August 01 2002
Development and potential of non-peptide antagonists for calcitonin-generelated peptide (CGRP) receptors: evidence for CGRP receptor heterogeneity
D. Wu;
D. Wu
1
1Cardiovascular Research, Boehringer Ingelheim Pharma KG, Birkendorfer Str. 65, D-88397 Biberach, Germany
Search for other works by this author on:
H. Doods;
H. Doods
1Cardiovascular Research, Boehringer Ingelheim Pharma KG, Birkendorfer Str. 65, D-88397 Biberach, Germany
Search for other works by this author on:
K. Arndt;
K. Arndt
1Cardiovascular Research, Boehringer Ingelheim Pharma KG, Birkendorfer Str. 65, D-88397 Biberach, Germany
Search for other works by this author on:
M. Schindler
M. Schindler
2
1Cardiovascular Research, Boehringer Ingelheim Pharma KG, Birkendorfer Str. 65, D-88397 Biberach, Germany
2To whom correspondence should be addressed (e-mail marcus.schindler@bc.boehringer-ingelheim.com)
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
March 08 2002
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© 2002 Biochemical Society
2002
Biochem Soc Trans (2002) 30 (4): 468–473.
Article history
Received:
March 08 2002
Citation
D. Wu, H. Doods, K. Arndt, M. Schindler; Development and potential of non-peptide antagonists for calcitonin-generelated peptide (CGRP) receptors: evidence for CGRP receptor heterogeneity. Biochem Soc Trans 1 August 2002; 30 (4): 468–473. doi: https://doi.org/10.1042/bst0300468
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.